Skye Bioscience, Inc. Common Stock (SKYE) — Cash Flow Reinvestment Rate

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Reinvestment Rate of 8.56x as of June 2014, reinvesting $67.83K (capex $67.83K ) from operating cash flow of $7.92K. Explore SKYE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

8.56x
(Capex + Investments) / Operating CF

Total Reinvested

$67.83K
Capex + Investments

Operating Cash Flow

$7.92K
USD

Capital Expenditures

$67.83K
USD

Skye Bioscience, Inc. Common Stock Cash Flow Reinvestment Rate (2012–2012)

Historical reinvestment intensity for Skye Bioscience, Inc. Common Stock across 1 annual periods. Also explore Skye Bioscience, Inc. Common Stock (SKYE) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Skye Bioscience, Inc. Common Stock (2012–2012)

Year-by-year capital reinvestment analysis for Skye Bioscience, Inc. Common Stock. For live market cap and broader valuation context, see how much is Skye Bioscience, Inc. Common Stock worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2012 0.00x $0.00 $1.93K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow